Search Results - "Avgeris, M."

Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma by Strati, A., Koutsodontis, G., Papaxoinis, G., Angelidis, I., Zavridou, M., Economopoulou, P., Kotsantis, I., Avgeris, M., Mazel, M., Perisanidis, C., Sasaki, C., Alix-Panabières, C., Lianidou, E., Psyrri, A.

“…Successful application of programmed death 1 (PD1) checkpoint inhibitors in the clinic may ultimately benefit from appropriate patient selection based upon…”
Get full text

The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients by Avgeris, M, Stravodimos, K, Fragoulis, E G, Scorilas, A

“…Background: Prostate cancer (PCa) is characterised by great heterogeneity of the disease progression rate. Tumours range from insignificant and not life…”
Get full text

Seroprevalence of diphtheria, tetanus and pertussis antibodies and Tdap vaccination in pregnant women in Greece – A cross- sectional study by Papailiou, S., Soldatou, A., Marmarinos, A., Avgeris, M., Papathoma, E., Sindos, M., Georgantzi, S., Rodolakis, Α., Iacovidou, N., Gourgiotis, D., Tsolia, M.

“…We performed a cross- sectional study in two maternity hospitals in Athens, Greece between 2017 and 2019 assessing seroprevalence and Geometric Mean Titres…”
Get full text

Inadequate protection against measles and rubella among pregnant women in Greece during the last measles outbreak by Papailiou, S., Soldatou, A., Marmarinos, A., Avgeris, M., Papathoma, E., Sindos, M., Georgantzi, S., Rodolakis, Α., Iacovidou, N., Gourgiotis, D., Tsolia, M.

Get full text

Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study by Psyrri, A., Fortpied, C., Koutsodontis, G., Avgeris, M., Kroupis, C., Goutas, N., Menis, J., Herman, L., Giurgea, L., Remenár, É., Degardin, M., Pateras, I.S., Langendijk, J.A., van Herpen, C.M.L., Awada, A., Germà-Lluch, J.R., Kienzer, H.R., Licitra, L., Vermorken, J.B.

“…EORTC 24971 was a phase III trial demonstrating superiority of induction regimen TPF (docetaxel, cisplatin, 5-fluorouracil) over PF (cisplatin/5-fluorouracil),…”
Get full text

360 Direct comparison of an ergonomic laparoscopic system with robotic surgery, in terms of operating speed, in an inanimate experimental laparoscopic radical prostatectomy setting by Tokas, T, Gözen, A.S, Avgeris, M, Tschada, A, Rassweiler, J

Get full text

Combining the ETHOS operating ergonomic platform, the 3D laparoscopic camera, and the Radius Surgical System (RSS) manipulators to improve ergonomic in laparoscopy by Tschada, A, Tokas, T, Gözen, A.S, Avgeris, M, Hruza, M, Klein, J, Rassweiler, J

Get full text

Sensitizing HRAS overexpressing head and neck squamous cell carcinoma (HNSCC) to chemotherapy by Rampias, T., Hoxhallari, L., Avgeris, M., Kanaki, Z., Telios, D., Giotakis, E., Giotakis, I., Scorilas, A., Psyrri, A., Klinakis, A.

Get full text

1139P - Sensitizing HRAS overexpressing head and neck squamous cell carcinoma (HNSCC) to chemotherapy by Rampias, T., Hoxhallari, L., Avgeris, M., Kanaki, Z., Telios, D., Giotakis, E., Giotakis, I., Scorilas, A., Psyrri, A., Klinakis, A.

“…HRAS is mutated or overexpressed in various cancers. Although numerous studies have demonstrated that HRAS mutations (HRASmut) promote chemoresistance in…”
Get full text

1139PSensitizing HRAS overexpressing head and neck squamous cell carcinoma (HNSCC) to chemotherapy by Rampias, T, Hoxhallari, L, Avgeris, M, Kanaki, Z, Telios, D, Giotakis, E, Giotakis, I, Scorilas, A, Psyrri, A, Klinakis, A

“…Abstract Background HRAS is mutated or overexpressed in various cancers. Although numerous studies have demonstrated that HRAS mutations (HRASmut) promote…”
Get full text

Short term starvation potentiates the efficacy of chemotherapy in triple negative breast cancer via metabolic reprogramming by Pateras, Ioannis S, Williams, Chloe, Gianniou, Despoina D, Margetis, Aggelos T, Avgeris, Margaritis, Rousakis, Pantelis, Legaki, Aigli-Ioanna, Mirtschink, Peter, Zhang, Wei, Panoutsopoulou, Konstantina, Delis, Anastasios D, Pagakis, Stamatis N, Tang, Wei, Ambs, Stefan, Warpman Berglund, Ulrika, Helleday, Thomas, Varvarigou, Anastasia, Chatzigeorgiou, Antonios, Nordström, Anders, Tsitsilonis, Ourania E, Trougakos, Ioannis P, Gilthorpe, Jonathan D, Frisan, Teresa

“…Chemotherapy (CT) is central to the treatment of triple negative breast cancer (TNBC), but drug toxicity and resistance place strong restrictions on treatment…”
Get full text

Abstract A183: Identification of an exon 31-deletion variant of Notch1 receptor with frequent expression in head and neck cancer by Psyrri, Amanda, Pectasides, Eirini, Avgeris, M, Klinakis, Apostolos, Scorilas, Andreas, Sasaki, Clarence, Fountzilas, George, Rampias, Theodoros

“…Abstract Introduction: Recently, whole genome sequencing studies revealed that loss of function somatic mutations in NOTCH1 receptor are present in more than…”
Get full text

S115 KALLIKREIN-RELATED PEPRIDASE 13 (KLK 13) GENE EXPRESSION IN URINARY BLADDER CANCER: CLINICAL EVALUATION AND PRELIMINARY RESULTS by Tokas, T, Stravodimos, K, Avgeris, M, Leotsakos, I, Frangiadis, E, Alamanis, C, Scorilas, A, Constantinides, C.A

Get full text

Quantitative expression analysis and study of the novel human kallikrein-related peptidase 14 gene (KLK14) in malignant and benign breast tissues by Papachristopoulou, Georgia, Avgeris, Margaritis, Charlaftis, Antonios, Scorilas, Andreas

“…Human kallikrein-related peptidase 14 gene (KLK14) is regulated by androgens and progestins. This gene is expressed in the central nervous system and endocrine…”
Get more information

03 - Combining the ETHOS operating ergonomic platform, the 3D laparoscopic camera, and the Radius Surgical System (RSS) manipulators to improve ergonomic in laparoscopy by Tschada, A., Tokas, T., Gözen, A.S., Avgeris, M., Hruza, M., Klein, J., Rassweiler, J.

Get full text